RWJBarnabas Health Rutgers Cancer Institute of New Jersey

https://cinj.org/

 

RWJBarnabas Health Rutgers Cancer Institute of New Jersey
J

Administration, Safety, and Dosing of Ribociclib for ER+/HER2- mBC

By RWJBarnabas Health Rutgers Cancer Institute of New Jersey FEATURING Jackie Lauria
By RWJBarnabas Health Rutgers Cancer Institute of New Jersey FEATURING Jackie Lauria
186 views
September 26, 2023
0 Comments
Login to view comments. Click here to Login
Videos
18:01
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "MRD-Directed Therapy in CLL - Ready for Pri…

Feat. J. Rhodes
09:27
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Fixed Duration Treatment in CLL

Feat. J. Kra
22:17
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Administration, Safety, and Dosing of Ribociclib for ER+/HER2- mBC

Feat. J. Lauria
51:13
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Advances in Surgical Care of the Oncology Patient: Panel Discussion

Feat. R. Alexander, J. Aikins, J. Benevenia, R. Lazzaro, T. Beninato, M. Kohli
02:51
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

The Impact of Clinical Trials in Cancer Care

Feat. H. Hochster, S. Goel
02:52
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Perspective on the Annual Oncology Clinical Practice and Research Su…

Feat. A. Evens
02:16
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

The Future of Advanced Care for Hematologic Malignancies

Feat. M. Matasar
02:51
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Black Women and Breast Cancer

Feat. C. Omene
17:35
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Lymphoma During Pregnancy

Feat. A. Evens